MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy

J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):950-2. doi: 10.1136/jnnp.74.7.950.

Abstract

Objectives: To investigate whether axonal damage in primary progressive (PP) multiple sclerosis (MS), as measured by proton magnetic resonance spectroscopy (HMRS) imaging and brain atrophy, is a function of T2 weighted brain lesion volume.

Methods: 34 PP MS patients were divided into two categories: low (<3 cm(3), n = 18) or high (>or=3 cm(3), n = 16) T2 lesion load (LL). An Index of Brain Atrophy (IBA) was calculated and HMRS metabolite ratios were derived from a central brain area centred at the corpus callosum.

Results: Patient groups did not differ with regard to clinical characteristics and showed lower mean IBA and mean N-acetylaspartate:creatinine (NAA:Cr) ratios compared to healthy controls.

Conclusion: PP patients with low and high brain T2LL have detectable brain atrophy and NAA:Cr reduction compared to healthy controls. In PP MS, T2 lesions alone are insufficient to explain the presence of brain atrophy and decrease in NAA:Cr.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / analysis
  • Atrophy
  • Brain / pathology*
  • Case-Control Studies
  • Creatinine / analysis
  • Female
  • Humans
  • Magnetic Resonance Spectroscopy*
  • Male
  • Middle Aged
  • Multiple Sclerosis
  • Protons

Substances

  • Protons
  • Aspartic Acid
  • N-acetylaspartate
  • Creatinine